Daratumumab, Venetoclax, and Azacitidine in Combination with HAA Regimen as Consolidation Chemotherapy for T-cell Acute Lymphoblastic Leukemia with High CD38 Expression
Year: 2025
Type: article
Source: Turkish Journal of Hematology
Authors: Lin-sen Feng, Hui-yuan Li, Ai Tang, Meng-li Xu, San-bin Wang
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4410126062
